Mutant (MT) KRAS codon 12 and 13 alleles in patients (pts) with metastatic colorectal cancer (mCRC): Assessment as prognostic and predictive biomarkers of response to panitumumab (pmab).
Marc Peeters
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Other Remuneration - Amgen
Jean-Yves Douillard
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Eric Van Cutsem
Research Funding - Amgen
Salvatore Siena
Consultant or Advisory Role - Amgen; AstraZeneca; Merck Serono; Roche
Kathy Zhang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Richard Thomas Williams
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jeffrey S. Wiezorek
Employment or Leadership Position - Amgen
Stock Ownership - Amgen